Background Portal vein thrombosis (PVT) may be associated with negative outcomes in
patients with liver cirrhosis. However, the prevalence and incidence of PVT in liver cirrhosis …

Much has evolved over the past 25 years regarding our understanding of the coagulopathy
of liver disease. Paradoxically, this form of coagulopathy is relatively hypercoagulability …

Portal vein thrombosis most commonly occurs as a complication of liver cirrhosis and can
result in worsening symptoms of portal hypertension, which often can be challenging to treat …

Liver cirrhosis and splanchnic vein thrombosis (SVT) are strictly correlated. Portal vein
thrombosis, the most common location of SVT, is frequently diagnosed in liver cirrhosis …

Abstract Background & Aims Patients with cirrhosis are considered in a haemostatic
balance, though weaker than in normal subjects. In these patients, however, the use of …

Direct oral anticoagulants (DOACs) have been a welcome addition to clinical practice due to
the practical advantages they confer over traditional anticoagulants. In many countries …

Portal Vein Thrombosis (PVT), a common complication of advanced liver disease, is defined
as an obstruction of the portal vein due to thrombus formation that can extend to the superior …

Background Portal vein thrombosis (PVT) leads to significant morbidity and mortality burden
in patients with cirrhosis. An improved understanding of the utility of anticoagulation in …

Objective To evaluate the efficacy and safety of anticoagulant therapy in patients with
cirrhotic PVT, and compare differences in efficacy and safety among different anticoagulants …

Background Direct oral anticoagulants (DOACs) are effective for the management of
thromboembolic disorders. However, bleeding remains a major concern in cirrhotic patients …